BioXcel Therapeutics, Inc. (NASDAQ:BTAI) Q4 2023 Earnings Call Transcript

Matt Wiley: Yes. So that’s a great question, and I appreciate it. I mean, right now, when you look at the price point of [Indiscernible] it’s just over $1,400 a month. So there does seem to be some pricing flexibility in that market and one that we continue to examine.

Operator: Thank you. We reached the end of our question-and-answer session. I’d like to turn the floor back over to management for any further or closing comments.

Vimal Mehta: Thank you, everyone, for joining us today and for your continued interest in BioXcel Therapeutics. Have a great day.

Operator: Thank you. That does conclude today’s teleconference and webcast. You may disconnect your line at this time, and have a wonderful day. We thank you for your participation today.